================================================================================
BIOLOGICAL MODELING PIPELINE CONSISTENCY ANALYSIS
================================================================================
Generated: 2025-06-24 00:03:20

EXECUTIVE SUMMARY
--------------------------------------------------------------------------------
• Total experiment runs analyzed: 22
• Pipeline stages with data: 3

NATURAL LANGUAGE TO ONTOLOGY STAGE
===================================

CellOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 4
     • Average consistency: 30.0%
     • Maximum consistency: 80.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     80.0% [████████░░] Endothelial Cell (CL:0000115)
     20.0% [██░░░░░░░░] Blood Vessel Endothelial Cell (CL:0000077)
     10.0% [█░░░░░░░░░] Endothelial (CL:0000115)
     10.0% [█░░░░░░░░░] Cancer Cell (CL:0001063)

  INCONSISTENT TERMS (< 50%):
     20.0% Blood Vessel Endothelial Cell (CL:0000077)
     10.0% Endothelial (CL:0000115)
     10.0% Cancer Cell (CL:0001063)

GeneOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 14
     • Average consistency: 19.3%
     • Maximum consistency: 80.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     80.0% [████████░░] Angiogenesis (GO:0001525)
     40.0% [████░░░░░░] Blood Vessel Morphogenesis (GO:0048514)
     30.0% [███░░░░░░░] Response to Drug (GO:0042493)
     20.0% [██░░░░░░░░] Negative Regulation of Angiogenesis (GO:0016525)
     10.0% [█░░░░░░░░░] Oxygen transport (GO:0015671)
     ... and 9 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Blood Vessel Morphogenesis (GO:0048514)
     30.0% Response to Drug (GO:0042493)
     20.0% Negative Regulation of Angiogenesis (GO:0016525)
     ... and 10 more

MeSH Terms:
-----------
  STATISTICS:
     • Total unique terms: 22
     • Average consistency: 15.5%
     • Maximum consistency: 60.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     60.0% [██████░░░░] Antineoplastic Agents (D000970)
     50.0% [█████░░░░░] Neoplasms (D009369)
     30.0% [███░░░░░░░] Angiogenesis Inhibitors (D019379)
     20.0% [██░░░░░░░░] Neovascularization, Pathologic (D018908)
     10.0% [█░░░░░░░░░] Drug Discovery (D0000783)
     ... and 17 more terms

  INCONSISTENT TERMS (< 50%):
     30.0% Angiogenesis Inhibitors (D019379)
     20.0% Neovascularization, Pathologic (D018908)
     10.0% Drug Discovery (D0000783)
     ... and 17 more

--------------------------------------------------------------------------------

ONTOLOGY TO CC3D CODE STAGE
============================

Code Similarity Analysis:
-------------------------
  STATISTICS:
     • Number of comparisons: 45
     • Average similarity: 6.8%
     • Minimum similarity: 0.2%
     • Maximum similarity: 21.4%

  OVERALL CODE CONSISTENCY: POOR

  PAIRWISE COMPARISONS:
     Runs 1-2: 5.4% [░░░░░░░░░░]
     Runs 1-3: 0.9% [░░░░░░░░░░]
     Runs 1-4: 2.2% [░░░░░░░░░░]
     Runs 1-5: 6.7% [░░░░░░░░░░]
     Runs 1-6: 4.2% [░░░░░░░░░░]
     Runs 1-7: 7.9% [░░░░░░░░░░]
     Runs 1-8: 0.8% [░░░░░░░░░░]
     Runs 1-9: 7.4% [░░░░░░░░░░]
     Runs 1-10: 1.6% [░░░░░░░░░░]
     Runs 2-3: 16.2% [█░░░░░░░░░]
     Runs 2-4: 9.0% [░░░░░░░░░░]
     Runs 2-5: 1.8% [░░░░░░░░░░]
     Runs 2-6: 3.4% [░░░░░░░░░░]
     Runs 2-7: 3.7% [░░░░░░░░░░]
     Runs 2-8: 15.8% [█░░░░░░░░░]
     Runs 2-9: 12.2% [█░░░░░░░░░]
     Runs 2-10: 4.1% [░░░░░░░░░░]
     Runs 3-4: 11.0% [█░░░░░░░░░]
     Runs 3-5: 4.9% [░░░░░░░░░░]
     Runs 3-6: 21.4% [██░░░░░░░░]
     Runs 3-7: 3.9% [░░░░░░░░░░]
     Runs 3-8: 16.4% [█░░░░░░░░░]
     Runs 3-9: 17.6% [█░░░░░░░░░]
     Runs 3-10: 3.8% [░░░░░░░░░░]
     Runs 4-5: 2.5% [░░░░░░░░░░]
     Runs 4-6: 18.8% [█░░░░░░░░░]
     Runs 4-7: 5.2% [░░░░░░░░░░]
     Runs 4-8: 13.0% [█░░░░░░░░░]
     Runs 4-9: 6.0% [░░░░░░░░░░]
     Runs 4-10: 2.2% [░░░░░░░░░░]
     Runs 5-6: 5.3% [░░░░░░░░░░]
     Runs 5-7: 3.9% [░░░░░░░░░░]
     Runs 5-8: 1.0% [░░░░░░░░░░]
     Runs 5-9: 3.5% [░░░░░░░░░░]
     Runs 5-10: 1.3% [░░░░░░░░░░]
     Runs 6-7: 4.8% [░░░░░░░░░░]
     Runs 6-8: 13.3% [█░░░░░░░░░]
     Runs 6-9: 13.6% [█░░░░░░░░░]
     Runs 6-10: 3.7% [░░░░░░░░░░]
     Runs 7-8: 1.7% [░░░░░░░░░░]
     Runs 7-9: 2.2% [░░░░░░░░░░]
     Runs 7-10: 0.2% [░░░░░░░░░░]
     Runs 8-9: 11.2% [█░░░░░░░░░]
     Runs 8-10: 5.7% [░░░░░░░░░░]
     Runs 9-10: 5.9% [░░░░░░░░░░]

--------------------------------------------------------------------------------

NATURAL LANGUAGE TO CC3D CODE (END-TO-END) STAGE
=================================================

CellOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 4
     • Average consistency: 30.0%
     • Maximum consistency: 80.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     80.0% [████████░░] Endothelial Cell (CL:0000115)
     20.0% [██░░░░░░░░] Blood Vessel Endothelial Cell (CL:0000077)
     10.0% [█░░░░░░░░░] Endothelial (CL:0000115)
     10.0% [█░░░░░░░░░] Cancer Cell (CL:0001063)

  INCONSISTENT TERMS (< 50%):
     20.0% Blood Vessel Endothelial Cell (CL:0000077)
     10.0% Endothelial (CL:0000115)
     10.0% Cancer Cell (CL:0001063)

GeneOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 14
     • Average consistency: 19.3%
     • Maximum consistency: 80.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     80.0% [████████░░] Angiogenesis (GO:0001525)
     40.0% [████░░░░░░] Blood Vessel Morphogenesis (GO:0048514)
     30.0% [███░░░░░░░] Response to Drug (GO:0042493)
     20.0% [██░░░░░░░░] Negative Regulation of Angiogenesis (GO:0016525)
     10.0% [█░░░░░░░░░] Oxygen transport (GO:0015671)
     ... and 9 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Blood Vessel Morphogenesis (GO:0048514)
     30.0% Response to Drug (GO:0042493)
     20.0% Negative Regulation of Angiogenesis (GO:0016525)
     ... and 10 more

MeSH Terms:
-----------
  STATISTICS:
     • Total unique terms: 22
     • Average consistency: 15.5%
     • Maximum consistency: 60.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     60.0% [██████░░░░] Antineoplastic Agents (D000970)
     50.0% [█████░░░░░] Neoplasms (D009369)
     30.0% [███░░░░░░░] Angiogenesis Inhibitors (D019379)
     20.0% [██░░░░░░░░] Neovascularization, Pathologic (D018908)
     10.0% [█░░░░░░░░░] Drug Discovery (D0000783)
     ... and 17 more terms

  INCONSISTENT TERMS (< 50%):
     30.0% Angiogenesis Inhibitors (D019379)
     20.0% Neovascularization, Pathologic (D018908)
     10.0% Drug Discovery (D0000783)
     ... and 17 more

Code Similarity Analysis:
-------------------------
  STATISTICS:
     • Number of comparisons: 45
     • Average similarity: 6.8%
     • Minimum similarity: 0.2%
     • Maximum similarity: 21.4%

  OVERALL CODE CONSISTENCY: POOR

  PAIRWISE COMPARISONS:
     Runs 1-2: 5.4% [░░░░░░░░░░]
     Runs 1-3: 0.9% [░░░░░░░░░░]
     Runs 1-4: 2.2% [░░░░░░░░░░]
     Runs 1-5: 6.7% [░░░░░░░░░░]
     Runs 1-6: 4.2% [░░░░░░░░░░]
     Runs 1-7: 7.9% [░░░░░░░░░░]
     Runs 1-8: 0.8% [░░░░░░░░░░]
     Runs 1-9: 7.4% [░░░░░░░░░░]
     Runs 1-10: 1.6% [░░░░░░░░░░]
     Runs 2-3: 16.2% [█░░░░░░░░░]
     Runs 2-4: 9.0% [░░░░░░░░░░]
     Runs 2-5: 1.8% [░░░░░░░░░░]
     Runs 2-6: 3.4% [░░░░░░░░░░]
     Runs 2-7: 3.7% [░░░░░░░░░░]
     Runs 2-8: 15.8% [█░░░░░░░░░]
     Runs 2-9: 12.2% [█░░░░░░░░░]
     Runs 2-10: 4.1% [░░░░░░░░░░]
     Runs 3-4: 11.0% [█░░░░░░░░░]
     Runs 3-5: 4.9% [░░░░░░░░░░]
     Runs 3-6: 21.4% [██░░░░░░░░]
     Runs 3-7: 3.9% [░░░░░░░░░░]
     Runs 3-8: 16.4% [█░░░░░░░░░]
     Runs 3-9: 17.6% [█░░░░░░░░░]
     Runs 3-10: 3.8% [░░░░░░░░░░]
     Runs 4-5: 2.5% [░░░░░░░░░░]
     Runs 4-6: 18.8% [█░░░░░░░░░]
     Runs 4-7: 5.2% [░░░░░░░░░░]
     Runs 4-8: 13.0% [█░░░░░░░░░]
     Runs 4-9: 6.0% [░░░░░░░░░░]
     Runs 4-10: 2.2% [░░░░░░░░░░]
     Runs 5-6: 5.3% [░░░░░░░░░░]
     Runs 5-7: 3.9% [░░░░░░░░░░]
     Runs 5-8: 1.0% [░░░░░░░░░░]
     Runs 5-9: 3.5% [░░░░░░░░░░]
     Runs 5-10: 1.3% [░░░░░░░░░░]
     Runs 6-7: 4.8% [░░░░░░░░░░]
     Runs 6-8: 13.3% [█░░░░░░░░░]
     Runs 6-9: 13.6% [█░░░░░░░░░]
     Runs 6-10: 3.7% [░░░░░░░░░░]
     Runs 7-8: 1.7% [░░░░░░░░░░]
     Runs 7-9: 2.2% [░░░░░░░░░░]
     Runs 7-10: 0.2% [░░░░░░░░░░]
     Runs 8-9: 11.2% [█░░░░░░░░░]
     Runs 8-10: 5.7% [░░░░░░░░░░]
     Runs 9-10: 5.9% [░░░░░░░░░░]

--------------------------------------------------------------------------------

RECOMMENDATIONS & INSIGHTS
================================================================================
ONTOLOGY CONSISTENCY ISSUES:
   • CellOntology shows low consistency (30.0%) in natural_to_ontology
     → Consider refining prompts for CellOntology term extraction
   • GeneOntology shows low consistency (19.3%) in natural_to_ontology
     → Consider refining prompts for GeneOntology term extraction
   • MeSH shows low consistency (15.5%) in natural_to_ontology
     → Consider refining prompts for MeSH term extraction
   • CellOntology shows low consistency (30.0%) in natural_to_code
     → Consider refining prompts for CellOntology term extraction
   • GeneOntology shows low consistency (19.3%) in natural_to_code
     → Consider refining prompts for GeneOntology term extraction
   • MeSH shows low consistency (15.5%) in natural_to_code
     → Consider refining prompts for MeSH term extraction

CODE GENERATION CONSISTENCY ISSUES:
   • ontology_to_code shows low code similarity (6.8%)
     → Consider using lower temperature or more specific prompts
   • natural_to_code shows low code similarity (6.8%)
     → Consider using lower temperature or more specific prompts

GENERAL RECOMMENDATIONS:
   • Run more experiments (5+ runs) for better statistical significance
   • Monitor consistency trends over time
   • Consider prompt engineering if consistency is below 70%
   • Archive low-performing experiment configurations

================================================================================
End of Analysis Report
================================================================================